PVLA vs REPL Stock Comparison
PVLA currently leads REPL in this stock comparison, with AIQ scores of 70 vs 60. The clearest difference is quality, while REPL has the stronger momentum profile.
What is the main difference between PVLA and REPL?
PVLA leads the current stock comparison as Palvella Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Palvella Therapeutics, Inc. vs Replimune Group, Inc.
PVLA leads
PVLA leads by 10 AIQ points, primarily on Quality and Risk Resilience.
Stable: 3 of 5 evidence groups support PVLA, and its signal state is cleanly positive.
Palvella Therapeutics, Inc.
Replimune Group, Inc.
The Algovestiq AIQ Score currently favors PVLA over REPL, 70 versus 60 as of Nov 15, 2026. PVLA's advantage is driven primarily by stronger quality and risk resilience, while REPL holds the stronger momentum profile. PVLA also shows the weaker technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PVLA today, and the comparison is rated Stable on stability. PVLA lead: Stable — the AIQ differential has held near 10 points over 30 sessions.
Compare Palvella Therapeutics, Inc. and Replimune Group, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare PVLA and REPL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality65 vs 35PVLA +30
- Risk Resilience47 vs 26PVLA +21
- Momentum84 vs 97REPL +13
3 of 5 evidence groups favor PVLA. PVLA’s edge is concentrated in quality and risk resilience; REPL keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +4
No signal started or stopped since the prior session; its 5 active signals are unchanged.
No factor moved materially.
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.59x)
- RSI Bearish Divergence — bearish, momentum, medium horizon
PVLA's lead widened by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — PVLA and REPL both carry a full feed there.
The central trade-off
PVLA (Palvella Therapeutics, Inc.): the stronger current systematic profile, led by quality and risk resilience.
REPL (Replimune Group, Inc.): the counter-case, on momentum, technicals — but at materially higher volatility, 100.6% against 75.1%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PVLAPVLA on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
REPLREPL on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
REPLREPL on the Momentum factor, by 13 points.
Lower downside
PVLAPVLA on Risk Resilience, by 21 points.
Analyst upside
PVLAPVLA on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | PVLA | REPL | Note |
|---|---|---|---|
| Implied upside to target | +55.6% | +37% | PVLA has more room |
| Target dispersion | +8.4% | +6.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 16 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor PVLA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PVLA | 70 vs 60 |
| Fundamentals | Even | revenue growth 0% vs 0%; EPS growth -11.8% vs 25%; TTM ROE -12.5% vs -27.9%; gross margin 0% vs 0%; operating margin 0% vs 0% |
| Valuation | Not covered | Not covered |
| Technicals | REPL | Price vs 50-day 6.2% vs 48.3%; vs 200-day 16.9% vs 118.9% |
| Risk Resilience | PVLA | Risk Resilience 47 vs 26 |
| Analyst expectations | PVLA | Target upside 55.6% vs 37% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of PVLA and REPL and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is moderate at 10 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PVLA.
How the comparison changed
120 daily snapshots · May 27 – Nov 13PVLA lead: Stable — the AIQ differential has held near 10 points over 30 sessions.
- Today
- PVLA +10
- 70 vs 60
- 7 sessions ago
- PVLA +7
- 67 vs 60
- 30 sessions ago
- PVLA +10
- 61 vs 51
- 90 sessions ago
- PVLA +19
- 71 vs 52
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 0 bearish / 1 neutral
No signal that the other name lacks.
5 bullish / 3 bearish / 1 neutral, conflicted
Only REPL
- Keltner Channel Breakout — bullish, volatility, short horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.59x)
- RSI Bearish Divergence — bearish, momentum, medium horizon
- RSI Overbought — bearish, momentum, short horizon
Both carry 5 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, TRIX Bullish Signal, Uptrend Structure Active.
REPL is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 2 points over the same session — price and model disagree (price -0.46%, AIQ +2 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.41%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1REPL closes the Quality gap — currently 30 points behind, the largest single contributor to PVLA's edge.
- 2REPL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
- 3PVLA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | PVLA | REPL |
|---|---|---|
| Revenue growth (YoY) | 0% | 0% |
| EPS growth (YoY) | -11.8% | 25% |
| Gross margin | 0% | 0% |
| Operating margin | 0% | 0% |
| Return on equity (TTM) | -12.5% | -27.9% |
| Debt to equity | 0 | 0.62 |
Performance
REPL leads 6 of 6 windows| Metric | PVLA | REPL |
|---|---|---|
| 1 week (5 sessions) | -13.3% | 1.2% |
| 1 month (20 sessions) | 26.7% | 101.6% |
| 3 months (63 sessions) | -0.7% | 49.6% |
| 6 months (126 sessions) | 33.5% | 344% |
| Year to date | 45.7% | 125.2% |
| 1 year (252 sessions) | 87% | 139.8% |
Technicals
REPL has the stronger structure| Metric | PVLA | REPL |
|---|---|---|
| RSI (14) | 52.6 | 72.1 |
| ADX (14) | 31.1 | 42.8 |
| Price vs 50-day | 6.2% | 48.3% |
| Price vs 200-day | 16.9% | 118.9% |
| Volatility (1M, annualized) | 75.1% | 100.6% |
Risk
PVLA is the more resilient| Metric | PVLA | REPL |
|---|---|---|
| Beta | 1.65 | 0.9 |
| Sharpe ratio | 1.12 | 1.3 |
| Sortino ratio | 1.87 | 2.57 |
| Max drawdown | -31.1% | -84.2% |
| Current drawdown | -13.3% | -6% |
| Annualized volatility | 84.5% | 187.9% |
| Value at risk (95%) | -6.9% | -8.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, PVLA or REPL?
On the Algovestiq AIQ Score, PVLA is the stronger of the two as of Nov 15, 2026, scoring 70 against REPL's 60. The edge comes from quality and risk resilience. REPL is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is PVLA or REPL the better buy right now?
PVLA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 3 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor PVLA over REPL?
The composite weights Quality, Value, Momentum and Risk Resilience. PVLA leads Quality by 30 points; PVLA leads Risk Resilience by 21 points; REPL leads Momentum by 13 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, PVLA or REPL?
Analyst price targets imply +55.6% upside for PVLA and +37% for REPL, so the Street currently favors PVLA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, PVLA or REPL?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, PVLA or REPL?
REPL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, PVLA or REPL?
REPL on the Momentum factor, by 13 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, PVLA or REPL?
PVLA is the more resilient of the two, so the other name carries the higher downside risk. PVLA on Risk Resilience, by 21 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is PVLA more profitable than REPL?
PVLA leads on the comparable margin measures — gross margin 0% vs 0%; operating margin 0% vs 0%; ttm roe -12.5% vs -27.9%.
Is PVLA's lead over REPL getting stronger or weaker?
PVLA lead: Stable — the AIQ differential has held near 10 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the PVLA vs REPL verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: REPL closes the Quality gap — currently 30 points behind, the largest single contributor to PVLA's edge; REPL generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; PVLA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about PVLA and REPL?
PVLA: 4 bullish / 0 bearish / 1 neutral. REPL: 5 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on PVLA is Golden Cross Active (bullish, long horizon). On REPL it is Golden Cross Active (bullish, long horizon).
Compare PVLA and REPL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.